 Prof.
William H. McCarthy
1. McCARTHY, WH. (1966) Substances in sera influencing
growth of sarcoma 180 in mice. Arch Surg 93: 967-970
2. McCARTHY, WH. (1966) Two systems of medical education:
a sociological view. Med J Aust. 2: 978-980
3. McCARTHY, WH. (1966) An assessment of the influence
of cueing items in objective examinations. J Med Educ. 41: 3-4.
4. McCARTHY, WH. (1967) The simulated patient management
problem: a technique for evaluating and teaching clinical competence.
J Med Educ 42: 15-17.
5. McCARTHY, WH. (1968) Evaluating patterns of surgical
clerkship programs. J. Med Educ 43: 367-372
6. McCARTHY, WH. (1968) Medical education in transition.
University of Sydney Medical Journal.
7. McCARTHY, WH. (1969)Report of conference on educational
testing in medicine. The University of Sydney Gazette 2: 18-20.
8. McCARTHY, WH. An evaluation model for medical education.
In: Educational Testing in Medicine". WH McCarthy & GW
Milton, (eds.) Faculty of Medicine, University of Sydney, 1969,
pp.13-19.
9. McCarthy, WH. Executive Director, "Simulation
in the evaluation of clinical competence". Film (10min). Produced
for Conference on Educational Testing in Medicine. 1969.
10. MCCARTHY, WH. (1970) A new synthetic absorbable
suture material: a clinical trial of PGA in general surgery. Aust
NZ J Surg 40: 220-223.
11. McCARTHY, WH. (1970) Improving large audience
teaching. The "programmed" lecture. B Br J Med Educ 4:
360-363.
12. McCARTHY, WH. The derivation of educational objectives
for the Medical School, the implication of educational objectives
for teaching methods, the basis of effective learning, Functions
of an evaluation system, Recent developments in evaluation methods,
The evaluation of teaching, Preparation of examination questions.
In: "Proceedings of the Workshops on Teaching Methods and Evaluation
in Medical Education". J Cuyegkeng (ed.). Association of Philippine
Medical Colleges, 1970.
13. MCCARTHY, WH. Feedback in the teaching of surgery.
In: "Teaching and Learning in the Medical School". Proceedings
of the Conference, August 1970.
14. BURKE, PJ, McCARTHY, WH & Milton GW (1971).
Imadazole carboxamide therapy in advanced malignant melanoma. Cancer
27: 744-750
15. MILTON, GW, McCARTHY, WH & CARLON, AS. (1971)
Malignant melanoma and vitiligo. Aust J. Dermatol 12: 131-142.
16. McCARTHY, WH. (1971) A programmed teaching method.
The University of Sydney Gazette. 3: 1-4.
17. McCARTHY, WH. (1971) Improving classroom instruction.
A programmed teaching method. J. Med Educ 46: 605-607.
18. McPARTLIN, JF & McCARTHY, WH. (1971) An appraisal
of diagnostic paracentesis of the abdomen. Br J Surg 58: 498-501.
19. McCARTHY, WH. (1971) Medical school examinations.
Tribal initiation or valid assessment of performance. Mod Med 12:
486-488.
20. McCARTHY, WH. (1971) Curriculum development in
the medical school. Med J Aust 1: 26-27.
21. McCARTHY, WH. A complicated abdominal problem.
In: "Clinical simulations, Selected Problems in Patient Management".C
McGuire, (ed.). Appleton,Century,Crofts, 1971, pp.113-115.
22. McCARTHY, WH. The role of the doctor in nursing
education. Nursing Times, January 20 1972.
23. McCARTHY, WH. Education and training for health
care. In: "Proceedings of Annual Forum". - University
of New South Wales, 1972.
24. McCARTHY, WH. (1972) An approach to the education
of the Asian in Australia. Med J Aust. 1: 16-19.
25. McCARTHY, WH. (1972) The Australasian Association
for Medical Education. Med J Aust 2: 792-795.
26. McCARTHY, WH. Application of educational ideas
to medical education. In: "The Education of the Doctor".
Proceedings of the Conference, University of Sydney, 1973.
27. COX, K, DUNSTAN, M & McCARTHY, WH. (1973)
Student opinion on a trial multiple choice examination in surgery.
Med J. Aust 2:511-512.
28. COX, K, LUDBROOK, J, McCARTHY, WH & DUNSTAN<
M, (1973) National comparisons in a trial examination in surgery.
Br J. Med Educ 7: 21-24.
29. MILTON, GW & McCARTHY,WH & DUNSTAN, M,
(1973) National comparisons in a trial examination in surgery. Br
J.Med Educ 7: 21-24.
30. MILTON GW & McCARTHY WH. (1973) Radical dissection
of axillary lymph nodes for malignant melanoma: technique and results.
Proc RACS 4th Gen Sci Meeting, Singapore.
31. McCARTHY WH, KOSSARD S, MILTON GW, COTTON G &
CARLON A. (1973) Immunotherapy of malignant melanoma: a clinical
trial. Canc 32: 97-103.
32. MILTON, GW & McCARTHY, WH. Non -specific immune
therapy of malignant melanoma. In: Proc 11th UICC, Florence, 1974.
33. MILTON, GW, & McCARTHY, WH. (1975) Immunotherapy
for malignant melanoma. Behring Inst Mitt 56: 251-256.
34. HERSEY, P, HONEYMAN, M, EDWARDS, A, ADAMS, E &
McCARTHY, WH. (1976) Antigens on melanoma cells detected by leucocyte-dependent
antibody assays of human melanoma antisera. Int J Cancer 18: 564-570.
35. HERSEY, P, MORGAN, G, McCARTHY, WH & MILTON,
GW. (1976) Previous pregnancy as a protective factor against death
from melanoma. Lancet 1: 451-452.
36. SHAW, HM, McCARTHY, WH & MILTON, GW. (1977)
Changing trends in mortality from malignant melanoma. Med J Aust
2: 77-80.
37. McCARTHY, WH, DONALDSON, E & HOLLOWS, F. (1977)
What should we teach? A consensus method to determine curriculum
content. J Med Educ 52:249-256.
38. MILTON, GW, SHAW, HM & McCARTHY,WH. Occult
primary malignant melanoma: factors influencing survival. Br J Surg
64: 805-808.
39. HERSEY, P & McCARTHY, WH. (1977) Immunotherapy
of solid tumours. Aust NZ J Surg 47: 701-706.
40. MORGAN, G, McCARTHY,WH & HERSEY, P. (1977)
Detection of carcinoembryonic-like antigen on melanoma cells by
leucocyte-dependent antibody assays. Br J Cancer 36: 446-452.
41. MURRAY, E, McCARTHY, WH & HERSEY, P. (1977)
Blocking factors against leucocyte-dependent melanoma antibody in
the sera of melanoma patients. Br J Cancer 36: 129-137.
42. McCARTHY, WH, DONALDSON, E, & HOLLOWS, FC.
(1978) What should we teach? A consensus method to determine curriculum
content. Aust J Ophthalmol 33: 129-137.
43. McCARTHY, WH, SHAW, HM & MILTON, GW. (1978)
Spontaneous regression of metastatic malignant melanoma. Clinical
Oncology 4: 203-207.
44. McCARTHY, WH, SHAW, HM & JONES, PH. (1978)
Laser surgery for malignant melanoma and superficial malignancies,
Aust NZ J Surg 48: 656-661.
45. MILTON, GW & McCARTHY, WH. (1978) Chemotherapy
for malignant melanoma: a brief review and personal experience.
Aust NZ J Surg 48: 53-55.
46. HERSEY, P, EDWARDS, A, MILTON, GW & McCARTHY
WH. Relationship of cell-mediated cytotoxicity against melanoma
cells to prognosis in melanoma patients. Br J Cancer 37: 505-513.
47. HERSEY, P, EDWARDS, AE, MURRAY E, McCARTHY, WH
& MILTON, GW. (1978) Sequential Studies of Melanoma Leucocyte-Dependent
Antibody Activity in Melanoma Patients. Eur J Cancer 14: 629-637.
48. SHAW, HM, MILTON, GW, FARAGO, G & McCARTHY,
WH. (1978) Endocrine influences on survival from malignant melanoma.
Cancer 42: 669-677.
49. SHAW, HM, MILTON, GW, McCARTHY, WH, FARAGO, G,
& DILWORTH, P. (1979) Effects of smoking on recurrences of malignant
melanoma. Med J Aust 1: 208-209.
50. HERSEY, P, MURRAY, E, WERKMEISTER, J & McCARTHY,
WH. (1979) Detection of a small molecular weight antigen on melanoma
cells by a human antiserum in leucocyte-dependent antibody assays.
Br J Cancer 40: 615-627.
51. WHITSED, H, McCARTHY, WH & HERSEY, P. (1979)
Nephelometric detection of circulating immune complexes using monoclonal
rheumatoid factor. J. Immunol Methods 29: 311-321.
52. HERSEY, P, EDWARDS, A, HONEYMAN, M & McCARTHY,
WH. (1979) Low natural killer cell activity in familial melanoma
patients and their relatives. Br J Cancer 40: 113-122.
53. McCARTHY, WH & STEPHENS, FO. Laser surgery
for melanoma and other malignancies. In: "Laser Surgery III,
Part I".Proc 4th Int Cong Laser Surgery. I Kaplan, (ed.). 1979,
pp. 193-196.
54. MILTON, GW & McCARTHY, WH. Local treatment
of advanced malignant melanoma. "Advances in Medical Oncology,
Research & Education". Vol.10. S. Kumer (ed.).Pergamon
Press, Oxford, 1979, pp. 99-101.
55. McCARTHY, WH. (1980) Special review. Clinical
surgery. Med J. Aust 2: 348.
56. HERSEY, P, EDWARDS, A & McCARTHY, WH. (1980)
Tumour related changes in natural killer cell activity in melanoma
patients. influence of stage of disease, tumour thickness and age
of patients. Int J Cancer 25: 177-194.
57. WERKMEISTER, J, ZAUNDERS, J, McCARTHY, WH &
HERSEY, P. (1980) Characterization of an inhibitor of cell division
released in tumour cell cultures. Clin Exp Immunol 41: 487-496.
58. WERKMEISTER, J, ZBROJA, R, McCARTHY, WH &
HERSEY, P. (1980) Release of factors inhibiting cell division from
cultured tumour cells. Clin Exp Immunol 40: 168-177.
59. WERKMEISTER, J, EDWARDS, A, McCARTHY, WH &
HERSEY, P. (1980) Prognostic significance of expression of antigens
on melanoma cells. Cancer immunol immunother 9: 233.
60. McCARTHY, WH, BLACK AL & MILTON, GW. (1980)
Melanoma in New South Wales. An epidemiological surgery. Cancer
46: 427-432.
61. McCARTHY, WH, MARTYN, Al, ROBERTS, G & DOBSON,
AJ. (1980) Melanoma in New South Wales 1970-76. Confirmation of
increased incidence. Med J Aust 2: 137-140.
62. SHAW, HM, McGOVERN, VJ, MILTON, GW, FARAGO, GA
& McCARTHY, WH. (1980) Histological features of tumours and
the female superiority in survival from malignant melanoma. Cancer
45: 1604-1608.
63. SHAW, HM, McGOVERN, VJ, MILTON, GW, FARAGO, GA
& McCARTHY, WH. (1980) Malignant melanoma: influence of site
of lesion and age of patient in the female superiority in survival.
Cancer 46:2731-2735.
64. MILTON, GW, SHAW, HM, FARAGO, GA & McCARTHY,
WH. (1980)Tumour thickness and the site and time of first recurrence
in cutaneous malignant melanoma (Stage I). Br J Surg 67: 543-546.
65. UNIVERSITY OF ALABAMA, BIRMINGHAM COMPREHENSIVE
CANCER CENTRE. Collaborative Melanoma Study. University of Alabama
in Birmingham, U.S.A. and the University of Sydney, Australia. Part
I. Statistical summary and analysis of 1091 clinical stage I melanoma
patients treated at the Melanoma Clinic, Sydney Hospital, The University
of Sydney, Australia. Birmingham, Alabama: University of Alabama
in Birmingham Comprehensive Cancer Centre, 1980. pp. 1-205.
66. WERKMEISTER, J, McCARTHY, WH & HERSEY, P.
(1981) Suppressor cell activity in melanoma patients. I. Relation
to tumour growth and immunoglobulin levels in vivo. Int J Cancer
28: 1-9.
67. WERKMEISTER, J, PHILLIPS, G, McCARTHY, WH &
HERSEY P. (1981) Suppressor cell activity in melanoma patients.
II. Concanavlin A induced suppressor cells in relation to tumour
growth and suppressor T cell subsets. Int J Cancer 28: 11-15.
68. ZAUNDERS, J, WERKMEISTER, J, McCARTHY, WH &
HERSEY P. (1981) Characterization of antigens recognized by natural
killer cells in cell culture supernatants. Br J Cancer 43: 5-12.
69. HERSEY, P, MURRAY, E & McCARTHY, WH. (1981)
Monitoring tumour growth by detection of melanoma antigens in sera
using leucocyte-dependent antibody inhibition assays. Cancer Immunol
Immunother 10: 67.
70. ROBERTS, G, MARTYN, AL, DOBSON, AJ & McCARTHY WH. (1981)
Tumour thickness and histological type in malignant melanoma in
New South Wales, Australia. Pathology 13: 763-770.
71. HERSEY, P, BINDON, C, EDWARDS, A, MURRAY, E, PHILLIPS,
G & McCARTHY WH. (1982) Induction of cytotoxic activity in human
lymphocytes against autologous and allogeneic melanoma cells in
vitro by culture with interleukin 2. Int J Cancer 28: 695-703.
72. SHAW, HM, McGOVERN, VJ, MILTON, GW, FARAGO, GA
& McCARTHY WH. (1982) The female superiority in survival in
clinical stage II cutaneous malignant melanoma. Cancer 49: 1941-1944.
73. MILTON, GW, SHAW, HM, McCARTHY, WH, PEARSON, L,
BALCH, CM & SOONG, SJ. (1982) Prophylactic lymph node dissection
in clinical Stage I cutaneous malignant melanoma: results of surgical
treatment in 1319 patients. Br J Surg 69: 1080111.
74. McGOVERN, VJ, SHAW, HM, MILTON, GW & McCARTHY
WH. (1982) Ulceration and prognosis in cutaneous malignant melanoma.
Histopathology 6: 399-407.
75. BALCH, CM, SOONG, SJ, MILTON, GW, SHAW, HM, McGOVERN,
VJ, MURAD, TK, McCARTHY, WH & MADDOX, WA. (1982) A comparison
of prognostic factors and surgical results in 1786 patients with
localized (Stage I) melanoma treated in Alabama, USA and New South
Wales, Australia. Ann Surg 196: 677-684.
76. McCARTHY, WH. Malignant Melanoma in: "Recent
Advances in Surgery". C Russell, (ed.). Churchill Livingstone,
Edinburgh, 1982, pp 95-100.
77. McCARTHY, WH, DOBSON, WH, MARTYN, AL & ROBERTS,
G. (1982) Melanoma in New South Wales 1970-76 - Surgical therapy
and survival. Aust NZ J Surg 52: 424-430.
78. HERSEY, P, HOBBS, A, EDWARDS A & McCARTHY
WH. (1982) Analysis of the relation between natural killer cell
activity and histologic features of lymphocytes infiltration and
partial regression of the primary tumour in melanoma patients. Cancer
Res 42: 363-368.
79. SCHEIBNER, A, MILTON, GW, McCARTHY, WH, &
PEARSON LJ. (1982) Multiple primary melanoma - a review of 90 cases.
Aust J Dermatol 23: 1-8.
80. HERSEY, P, EDWARDS, A, McCARTHY, WH & MILTON,
GW. Tumour related changes and prognostic significance of natural
killer cell activity in melanoma patients. In: "Natural Cell
Mediated Immunology" Vol. 2. RR Herberman (ed.). Academic Press,
New York, 1982, pp. 1167-1174.
81. HERSEY, P & McCARTHY WH. The nature and significance
of melanoma antigens recognized by human subjects. In: "Melanoma
Antigens and Antibodies". Reisfeld & Ferrono, (eds.). Plenum
Press, New York, 1982, pp. 187-209.
82. HERSEY,P, EDWARDS, A, MURRAY, E, McCARTHY, WH
& MILTON, GW. (1983) Prognostic significance of leukocyte dependent
antibody activity in melanoma patients. J Nat Cancer Inst 71: 45-53.
83. HERSEY, P, BRADLEY, M, HASIC, E, HARAN, G, EDWARDS,
A & McCARTHY, WH. (1983) Immunological effects of solarium exposure.
Lancet 1: 545-548.
84. BINDON, C, CZERNIECKE, M, RUELL, R, EDWARDS, A,
McCARTHY, WH, HARRIS R & HERSEY P. (1983) Clearance rates and
systemic effects of intravenously administered interleukin 2 (IL2)
containing preparations in human subjects. Br J Cancer 47:123-133.
85. SCHEIBNER, A, McCARTHY, WH, MILTON, GW & NORLAND,
JJ. (1983) Langerhans cell and melanocyte distribution in "normal"
human epidermis. Preliminary report. Aust J Dermatol 24: 9-16.
86. KOURTESIS, GJ, McCARTHY, WH, & MILTON, GW.
(1983) Major amputations for melanoma. Aust NZ J Surg 53: 240-244.
87. HERSEY, P, GRACE, J, MURRAY, E, PALMER, A &
McCARTHY, WH. (1983) Expression of THY-1 antigen on human melanoma
cells.Int J Cancer 32: 21-25.
88. BINDEN, C, HERSEY, P, RUELL, P, EDWARDS, A &
McCARTHY, WH & HARRIS, R. (1983) Clearance of systemically administered
interleukin 2 (IL2) from the circulation of human subjects. Br J
Cancer 47: 123-133.
89. SCHEIBNER, A, MILTON, GW & McCARTHY, WH. (1983)
Langerhans cells in cutaneous malignancies. Aust NZ J Surg 53: 364-365.
90. HERSEY, P, BINDON, C, CZERNIECKE, M, WASS, J &
McCARTHY WH. (1983) Inhibition of interleukin 2 production by factors
released from tumour cells. J Immunol 131: 2837-2842.
91. BALCH, CM, SOONG, SJ, MILTON , GW, SHAW, HM, McGOVERN,
VJ, McCARTHY, WH, MURAD, TM & MADDOX, WA. (1983) Changing trends
in cutaneous melanoma over a quarter century in Alabama, U.S.A.
and New South Wales, Australia. Cancer 52: 1748-1753.
92. McCARTHY, WH, SHAW, HM, MILTON, GW, & McGOVERN,
VJ. (1983) Melanoma in New South Wales, Australia: experience at
the Sydney Melanoma Unit. Ibid, pp. 371-378.
93. HERSEY, P, EDWARDS, A & McCARTHY, WH. (1984)
No evidence for an association between natural killer cell activity
and prognosis in melanoma patients. Nat Imm Cell Growth Reg 3: 87-94.
94. ROSSLEIGH M & McCARTHY, WH. (1984) Coincidental
diagnosis of clinically undetectable primary breast carcinoma with
a gallium-67 study performed for assessment of spread of malignant
melanoma. Aust NZ J Surg 54: 391-392.
95. HERSEY, P, MURRAY, E, GRACE, J & McCARTHY,
WH. (1985) Quantitative analysis of lymphocyte populations in histological
sections of cutaneous melanoma. Pathology 17: 385-391.
96. HERSEY, P, HASIC, E, MACDONALD, M, EDWARDS, A,
SPURLING, A, COATES, AS, MILTON, GW & McCARTHY, WH. (1985) Effects
of recombinant leukocyte interferon (rlFN-aA) on tumour growth and
immune responses in patients with metastatic melanoma. Bri J Cancer
51: 815-826.
97. McCARTHY, WH. Executive Producer, "Understanding
Cancer". Three films: 1: 'THe Search for a Cause'(50mins);
II: 'The Patients' Story'(46mins); and 111: 'The Road to Recovery"
(50 Mins). University of Sydney Television Service. 1984. Bronze
Award-Documentary film, International Film, T.V. Festival-New York).
98. MILTON, GW & McCARTHY, WH. (1984) The treatment
of skin cancer. Monograph, IUCC.
99. MALDEN, LT, COATES, AS, MILTON, GW, McCARTHY,
WH, LEVI, JA, WOODS, RL, BYRNE, MJ, REYNOLDS, PM, FOX, RM, HEDLEY,
DW et al. (1984) Mitolactol chemotherapy of malignant melanoma:
a phase 11 study. Cancer treat Rep 68: 1045-1046.
100. VINCENT, PC, JOYCE, RM, CROAKER, G, YOUNG, G,
MILTON, GW & McCARTHY, WH. (1985) Semi-solid cultures of primary
melanomas and their correlation with histopathological features.
Pathology 17: 360-364.
101. McCARTHY, WH. "Understanding Cancer".
Book of the Television Series. ABC Enterprises. 1985.
102. McCARTHY, WH & COATES, AS. (1985) The dyusplastic
naevus syndrome. Identifying the at-risk patient. Patient Management,
June, 47-56.
103. URIST, MM, BALCH, CM, SOONG, SJ, MILTON, GW,
SHAW, HM, McGOVERN, VJ, MURAD, TK, McCARTHY WH & MADDOX, WA.
(1985) Head and neck melanoma in 534 clinical stage 1 patients:
a prognostic factors analysis and results of surgical treatment.
An Surg 200: 769-775.
104. SHAW, HM, BALCH, CM, SOONG, SJ, MILTON, GW &
McCARTHY, WH. (1985) Prognostic histopathological factors in malignant
melanoma. Pathology 17: 271-274.
105. SHAW, HM, BEATTIE, C, McCARTHY, WH & MILTON,
GW. (1985) Melanoma: differing clinical patterns in older men and
women. Geriatric Medicine Today 4: 31-43.
106. SHAW, HM, BEATTIE, C, McCARTHY, WH & MILTON
GW. (1985) Late relapse from cutaneous stage 1 malignant melanoma.
Arch Surg 120: 1155-1159.
107. McCARTHY, WH, SHAW, HM, & MILTON, GW. (1985)
Efficacy of elective lymph node dissection in 2347 clinical stage
1 malignant melanoma patients. Surg Gynecol Obstet 161: 575-580.
108. MILTON, GW, SHAW, HM & McCARTHY, WH. (1985)
Resection margins for melanoma. Aust NZ J Surgery 55: 225-226.
109. MILTON, GW, SHAW, HM & McCARTHY, WH. (1985)
Subungual malignant melanoma: a disease entity separate from other
forms of cutaneous melanoma. Aust J Dermatol 26: 61-64.
110. SUTHERLAND, C, SHAW, HM, ROBERTS, C, GRACE, J,
STEWART, MM, McCARTHY, WH, & KEFFORD, RF. (1986) Harvey-ras
oncogene restriction fragments alleles in familial melanoma kindreds.
Br J Cancer 54: 787-790.
111. HERSEY, P, COATES, A & McCARTHY, WH. (1986)
Comparative study on the effects of recombinant alpha 2 interferon
on immune function in patients with disseminated melanoma. J Biol
Response Modifiers 5: 236-250.
112. McCARTHY, WH. (1986) Melanoma - the silent killer.
Forceps. 4: 241-244.
113. HERSEY, P, MACDONALD, M, HALL, C, SPURLING, A,
EDWARDS, A, COATES A 7 McCARTHY, WH. (1986) Immunological effects
of recombinant interferon alpha-2 (IFN Alfa-2a) in patients with
disseminated melanoma. Cancer 57: 1666-1674.
114. SCHEIBNER, A, HOLLIS, DE, McCARTHY, WH, &
MILTON, GW. (1986) Effects of sunlight exposure on langerhans cells
and melanocytes in human epidermis. Aust J Dermatol 27: 35-41.
115. McCARTHY, WH. (1987) Malignant melanoma and the
pharmacist. Aust pharmacist 6: 26-28.
116. MILTON, GW, McCARTHY, WH & SHAW, HM. (1987)
Thin malignant melanoma changing trends in treatment. Mod Med 30:
84-91.
117. SHAW, HM, McCARTHY, WH & MILTON, GW. (1987)
Thin malignant melanoma and recurrence potential. Arch Surg 122:
1147-1150.
118. KEFFORD, RF, SHAW, H & McCARTHY, WH. The
Ha-ras oncogene in familial melanoma. In: "Melanoma 4. Cancer
Treatment and Research". WL McGuire (ed.). Boston, Martinus
Nijhoff, 1987, pp.
119. D'ALESSANDRO B, ZARDAWI, I, GRACE, J, McCARTHY,
WH & HERSEY, P. (1987) Immunohistological evaluation of MHC
Class I & II antigen expression on naevi and melanoma - relation
to biology of melanoma. Pathology 19: 339-346.
120. HERSEY, P, EDWARDS, E, COATES, A, SHAW, H McCARTHY,
WH & MILTON, GW. (1987) Evidence that treatment with vaccinia
melanoma cell lysates may improve survival in patients with stage
II melanoma. Cancer Immunol Ummunother 25: 257-265.
121. McCARTHY, WH, SHAW, HM, THOMPSON, JF & MILTON,
GW. (1988) Time and frequency of recurrence of cutaneous stage I
malignant melanoma: guidelines for follow-up. Surg Gynecol Obstet
166: l497-1502.
122. KEFFORD, RF, SHAW, HM, McCARTHY, WH. The Ha-ras-1
oncogene and the molecular genetics of human melanoma. In: Malignant
Melanoma: Biology, Diagnosis and Therapy ". L. Nathanson &
WH McGuire (eds). Kluwer Academic Publishers, Boston, 1988, pp.
63-70.
123. SCHEIBNER, A, McCARTHY, WH & NORLAND, JJ.
Age and seasonal variation in melanocyte distribution in normal
human epidermis. In: "Cutaneous Aging". AM Kligman &
Y Takase (eds.). Tokyo, University of Tokyo Press, 1988, pp. 201-211.
124. McCARTHY, WH & SHAW, HM. (1989) Skin cancer
in Australia. Med J Aust 150: 469-470.
125. SHAW, HM, McCARTHY, SW, McCARTHY, WH, THOMPSON,
JF & MILTON, GW. (1989) Thin regressing malignant melanoma:
significance of concurrent regional lymph node metastases. Histopathology
15: 233-237.
126. McCARTHY, WH. (1990) Enhancing the prospects
for reduction of the incidence and mortality of melanoma. Trans
Menzies Found 15: 233-237.
127. RIVERS, JK, McCARDLE, CA, GUPTA, A, McCARTHY,
SW, O'BRIEN, CJ, & McCARTHY, WH. (1989) Recurrent melanoma after
topical retinol. Lancet ii: 1393.
128. RIVERS, JK, SHAW, HM, MILTON GW & McCARTHY,
WH. (1990) Polymyositis in association with melanoma. Arch Dermatol
126: 686-687.
129. McCARTHY, WH & SHAW, HM. (1990) Trends in
the epidemiology, diagnosis and management of melanoma, surgical
treatment of primary melanoma. Cancer Forum 14: 6-10.
130. McCARTHY, WH & RIVERS, JK. (1990) How to
treat melanoma. Aust Doctor Weekly 11 May. I-VIII.
131. McCARTHY, WH & RIVERS, JK. Can early melanoma
be diagnosed? In: "Cutaneous Melanoma, Biology and Management".
N. Cascinelli, M Santimani & Veronesi (eds.). Masson, Milan,
1990, pp. 113-125.
132. LLOYD, PJ, McCARTHY,WH & NOLAN, JM. (1990)
The "beds to the west" scheme: the politics and outcomes
of the 1982 New South Wales hospital rationalisation programme.
Med J Aust 153: 486-491.
133. MARKS, R & McCARTHY WH. (1990) Skin cancer:
increasing incidence and public awareness. Med J Aust 153: 505-506.
134. KHADRA, M, THOMPSON JF, MILTON GW & McCARTHY,
WH. (1990) The justification for surgical treatment of metastatic
melanoma of the gastrointestinal tract. Surg Gynecol Obstet 171:
413-415.
135. KEFFORD, RF, SALMON, J, DONALD, JA, McCARTHY,
WH & SHAW HM.(1991) Hereditary melanoma in Australia: variable
association with dysplastic nevi and absence of genetic linkage
to chromsome Ip. Cancer Genet Cytogenet 51: 45-55.
136. RIVERS, JK, McCARTHY, SW, SHAW HM, JONES, AS,
GLASZIOU, P, DORAN, TJ & McCARTHY, WH. (1991) Patients with
thick melanomas surviving at least ten years: histological, cytometric,
and HLA analyses. Histopathology 18: 339-346.
137. TEFANY, FJ, BARNETSON, RS, HALLIDAY, GM, McCARTHY,
SW & McCARTHY, WH. (1991) Immunocytochemical analysis of the
cellular infiltrate in primary regressing and non regressing malignant
melanoma. J Invest DSermatol 97: 197-202.
138. RIVERS, JK & McCARTHY, WH. (1991) No effect
of topical tretinoin on lentigo maligna. Arch Dermatol 127: 129.
139. HALLIDAY, GM, RIVERS, JK, & McCARTHY, WH.
(1991) Intransit melanoma: cellular response to autologous cytokine
injection. Reg Cancer Treat 4: 69-74.
140. ROSENTHAL, MA, BULL, CA, COATES, AS, STEVENS,
G, McCARTHY, WH, MAMEGHAN, H & KEFFORD, RF. (1991). Synchronous
cisplatin infusion during radiotherapy for the treatment of metastatic
melanoma. Eur J Cancer 27: 1564-1566.
141. STEPHENS FO, MARSDEN FW, STOREY DW, THOMPSON
JF, McCARTHY WH, RENWICK SB, NIESCHE FW, BELL JM & WATSON LD.
(1991) Developments in surgical oncology - past, present and future
trends. Med J Aust 155: 803-807.
142. O'BRIEN CJ, COATES AS, PETERSEN SCHAEFER K, SHANNON
K, THOMPSON JF, MILTON GW & McCARTHY WH. (1991) Experience with
998 cutaneous melanomas of the head and neck over 30 years. Am J
Surg 162: 310-314.
143. BALCH CM, SOONG SJ, SHAW HM, MADDOX WA, URIST
MM, McCARTHY WH, MILTON GW. Changing trends in the clinical and
pathologic features of melanoma. In: "Cutaneous Melanoma".
CM Balch, AN Houghton, GW Milton, AJ Sober & SJ Soong (eds.).
Lippincott, Philadelphia, 1992 pp. 40-45.
144. BALCH CM, SOONG SJ, SHAW HM, URIST MM & McCARTHY
WH. An analysis of prognostic factors in 8500 patients with cutaneous
melanoma. Ibid, pp. 165-167.
145. BALCH CM, CASCINELLI N, DRZEWIECZI KT, ELDH J,
MacKIE RM, McCARTHY WH, McLEOD GR, MORTON DL, TAKEMATSU H, TONAK,
J & WONG J. A comparison of prognostic factors worldwide. Ibid,
pp. 188-199.
146. FITZPATRICK TB, MILTON GW, BALCH CM, SHAW HM,
McCARTHY WH & SOBER AJ. Clinical characteristics. Ibid, pp.
223-233.
147. SINGLETARY SE, BALCH CM, URIST MM, McCARTHY WH
& CASCINELLI N. Surgical treatment of primary melanoma. Ibid,
pp. 269-274.
148. AMES FC, BALCH CM & McCARTHY WH. Axillary
Lymph node dissection. Ibid, pp. 384-391.
149. SOONG SJ, SHAW HM, BALCH CM, McCARTHY WH, URIST
MM & LEE JY. Predicting survival and recurrence in localized
melanoma: a multivariate approach. Ibid, pp. 191-195.
150. McCARTHY WH, SHAW HM, CASCINELLI N, SANTINAMI
M & BELI, Elective lymph node dissection for melanoma: two perspectives.
Ibid, pp. 202-213.
151. SALMON JA, RIBERS JK, DONALD JA, SHAW HM, McCARTHY
WH & KEFFORD RF. (1992) Clinical aspects of hereditary melanoma
in Australia. Cytogenet Cell Genet 59: 170-173.
152. SHAW HM, RIVERS JK, McCARTHY SW & McCARTHY
WH. (1992) Cutaneous malignant melanomas exhibiting unusual biologic
behavior. World J Surg 16: 191-195.
153. SHAW HM, & McCARTHY WH. (1992) Late recurrence
of melanoma. J Am Acad Dermatol 26: 281.
154. SHAW HM & McCARTHY WH. (1992) Small diameter
malignant melanoma: a common diagnosis in New South Wales, Australia.
J Am Acad Dermatol 27: 679-682.
155. SHAW HM & McCARTHY WH. (1993) Small diameter
malignant melanoma: a common diagnosis in New South Wales, Australia.
Dermatol Digest 5: 4.
156. SHAW HM, INGVAR C & McCARTHY WH.(1992) Iliac
node dissection for stage II melanoma. Letter. Plast Reconstr surg
90: 537-538.
157. SHAW HM, MCCARTHY WH & INGVAR C. (1992) The
effects of surgical treatment on survival and local recurrence of
cutaneous malignant melanoma. Letter. Cancer 70: 1649-1651.
158. McCARTHY WH. (1992) Melanoma in Australia. Skin
Ca Found J 10: 25-26.
159. QUINN MJ, WIKRAMANAYAKE PR, THOMPSON JF, &
McCARTHY WH. (1992) Non subungual melanomas of the hand. J Hand
Surg 17B: 433-436.
160. SEGELOV JN, COATES AS & McCARTHY WH. (1992)
Metastatic melanoma presenting at diagnosis as a testicular mass.
Aust NZ J Med 22: 701.
161. SHAW HM, McCARTHY WH & INGVAR C. (1993) Surgical
Management of BANS malignant melanoma. letter. Surgery 113: 124--126.
162. LAM AWP, THOMPSON JF & McCARTHY WH, (1993)
Unilateral periformis syndrome in a patient with previous melanoma.
Aust NZ J Surg 63: 152-153.
163. SHAW HM & McCARTHY WH. (1993) The effects
of surgical treatment on survival and local recurrence of cutaneous
malignant melanoma. Reply to Letter. Cancer 71: 3792-3793.
164. McCARTHY WH. (1993) The management of melanoma.
Aust Fam Physician 22: 1177-1186.
165. McCARTHY WH. (1993) Malignant melanoma - keys
to diagnosis. Mod Med August: 18-34
166. UREN RF, HOWMAN-GILES RB, SHAW HM, THOMPSON JF
& McCARTHY WH. (1993) Lymphoscintigraphy in high risk melanoma
of the trunk: predicting draining node groups, defining lymphatic
channels and locating the sentinel node. J Nucl Med 34: 1435-1440.
167. SHAW HM,& McCARTHY WH. Skin cancers and ozone
layer depletion In: "Health in the Greenhouse". CE Ewan,
EA Bryant, GD Calvert & JA Garrick (eds). AGPS Press, Canberra,
1993, pp. 57-66.
168. MATHUR MN, THOMPSON JF, O'BRIEN CJ, DAVIDSON
TI & McCARTHY WH. (1993) Naevoid basal cell carcinoma (Gorlin's)
syndrome: a case report and literature review. Aust NZ J Surg 63:
413-415.
169. DUNN SM, PATTERSON PU, BUTOW PN, SMARTT HH, McCARTHY WH &
TATTERSALL MH. (1993) Cancer by another name: a randomized trial
of the effects of euphemism and uncertainty in communicating with
cancer patients. J Clin Oncol 11: 989-996.
170. RAGHAVAN D, ZALCBERG JR, GRYGIEL JJ, TERIANA
N, COX KM, McCARTHY W & FLYNN M. (1994) Multiple atypical nevi:
a cutaneous marker of germ cell tumors. J Clin Oncol 12: 2284-2287.
171. SHAW HM,& McCARTHY WH. (1994) Melanoma recurrence
after wide excision. Is a wide excision justified? Letter. Ann Surg
219: 107-108.
172. McCARTHY WH & SHAW HM. The influence of prognostic factors
on melanoma management. In: "Malignant Melanoma. Medical and
Surgical Management". FJ LeJeune, PK Chaudhuri & TK Das
Gupta (eds.). McGraw-Hill Inc, New York, pp. 171-186. 1994
173. McCARTHY SW, CROTTY KA, PALMER AA, NG ABP, McCARTHY
WH & SHAW HM. (1994) Cutaneous malignant melanoma in teenagers.
Histopathology 24: 453-461.
174. SHAW HM, McCARTHY WH & THOMPSON JF. (1994)
Survival superiority of females with melanoma. Letter. Arch Surg
129: 1343-1344.
175. HILL DA, GUINEA AI & McCARTHY WH. (1994).
Formative assessment: a student perspective. Med Ed 28: 394-399.
176. UREN RF, HOWMAN-GILES RB, THOMPSON JF, SHAW HM,
QUINN MJ, O'BRIEN CJ & McCARTHY WH. (1994) Lymphoscintigraphy
to identify sentinel lymph nodes in patients with melanoma. Melanoma
Res 4: 395-399.
177. UREN RF, HOWMAN-GILES RB, SHAW HM, THOMPSON JF,
& McCARTHY WH.(1993) Lymphoscintraphy in high-risk melanoma
of the trunk: Predicting draining node groups, defining lymphatic
channels and locating the sentinel node. J Nucl Med 34: 1435-1440.
178. HILL DA, McCARTHY WH & GUINEA A. (1994) Teaching
critical decision-making skills to students concerning patients
with acute abdominal pain. Medical Teacher 16: 2-3.
179. HILL DA, McCARTHY WH & Guinea A. (1995) Learning
to manage patients with acute abdominal pain: a study guide for
medical students. Medical Teacher 17: 1.
180. McCARTHY WH. Malignant melanoma in Australia.
Sun & Skin News (In press)
181. UREN RF, HOWMAN-GILES RB, THOMPSON JF, SHAW HM
& McCARTHY WH. (1995) Lymphatic drainage from peri-umbilical
skin to internal mammary nodes. Clin Nucl Med 20: 254-255.
182. COATES AS, INGVAR CI, PETERSEN-SCHAEFER K, SHAW
HM, MILTON GW, O'BRIEN CJ, THOMPSON JF & McCARTHY WH. (1995)
Elective lymph node dissection in patients with primary melanoma
of the trunk and limbs treated at the Sydney Melanoma Unit from
1960 to 1991. J Am Coll Surg 180: 402-409.
183. SHAW HM & McCARTHY WH. Melanoma. In: "Update
in Men's Health: Strategies to Reduce Morbidity and Mortality".
P Browne, P Collett & C Ovadia (eds). Alpha Biomedical Communications,
Broadway, pp.77-82. 1995
184. MENZIES SW, CROTTY KA & McCARTHY WH. (1995)
The morphologic criteria of the pseudopod in surface microscopy.
Arch Dermatol 131: 436-440.
185. McCARTHY WH, THOMPSON JF & UREN RF. (1995)
Minimal-access surgery for stagin of malignant melanoma. Invited
Commentary. Arch Surg 310: 659-660.
186. RIVERS JK, MacLENNAN R, KELLY JW, LEWIS AE, TATE
BJ, HARRISON S & McCARTHY WH. (1995) The Eastern Australian
Childhood nevus study: prevalence of atypical nevi, congenital nevus-like
nevi, and other pigmented lesions. J Am Acad Dermatol 32: 957-963.
187. THOMPSON JF, McCARTHY WH, BOSCH CMJ, O'BRIEN
CJ, QUINN MJ, PARAMAESVARAN S, CROTTY K, McCARTHY SW, UREN RF &
HOWMAN-GILES R. (1995) Sentinel lymph node status as an indicator
of the presence of metastatic melanoma in regional lymph nodes.
Melanoma Res 5: 255-260.
188. O'BRIEN CJ, URE RF, THOMPSON JF, HOWMAN-GILES
RB, PETERSEN-SCHAEFER K, SHAW HM, QUINN MJ & McCARTHY WH. (1995)
Prediction of potential metastatic sites in cutaneous head and neck
melanoma using lymphoscintigraphy. Am J Surg 170: 461-466.
189. SHAW HM & McCARTHY WH. (1995) Melanoma recurrence
after wide excision. Is a wide excision justified? Further letter
to the Editor. Ann Surg 221: 113-114.
190. COATES AS, INGVAR CI, PETERSEN-SCHAEFER K, SHAW
HM, MILTON GW, O'BRIEN CJ, THOMPSON JF & McCARTHY WH. (1995)
Elective lymph node dissection. Letter. J Am Coll Surg 181: 582-583.
191. MENZIES SW, INGVAR C, CROTTY K & McCARTHY
WH. "An Atlas of Surface Microscopy of Pigmented Skin Lesions".
McGraw-Hill, Sydney, 1996.
192. MENZIES SW, INGVAR C & McCARTHY WH. (1996)
A sensitivity and specificity analysis of the surface microscopy
features of invasive melanoma. Melanoma Res 6: 55-62.
193. McCARTHY WH. Secondary prevention of skin cancer
in Australia. In: "Pigment Cell". Vol. 11. RM MacKie,
(ed.). Karger, Basel, pp 31-42. 1996
194. McCARTHY WH. (1996) Sun damage. Check 295: 3-24.
195. GRULICH AE, BATAILLE V, SWERDLOW AJ, NEWTON-BISHOP
JA, CUZICK J, HERSEY P & McCARTHY WH. (1996) Naevi and pigmentary
characteristics as risk factors for melanoma in a high-risk population:
a case-control study in New South Wales, Australia. Int J Cancer
67: 485-491.
196. McCARTHY WH & SHAW HM. Melanoma. In: "Surgical
Oncology". TG Allen-Marsh (ed.). Chapman and Hall, London,
pp 393-399, 1996.
197. McCARTHY WH, UREN RF & THOMPSON JF. (1996)
How lymphoscintigraphy aids melanoma treatment. Skin Ca Found J
14: 32-35.
198. UREN RF, HOWMAN-GILES RB, THOMPSON JF, QUINN
MJ, O'BRIEN CJ, SHAW HM & McCARTHY WH. (1996) Lymphatic drainage
to triangular intermuscular space lymph nodes in patients with melanoma
on the back. J Nucl Med 37: 934-936.
199. QUINN MJ, THOMPSON JF, CROTTY K, McCARTHY WH
& COATES AS. (1996) Subungual melanoma of the hand. J Hand Surg
(Am) 21A: 506-511.
200. McCARTHY WH, SHAW HM, McCARTHY SW, RIVERS JK
& THOMPSON JF. (1996) Cutaneous melanomas that defy conventional
prognostic indicators. Semin Oncol 23: 709-713.
201. MENZIES S, INGVAR C, CROTTY K & McCARTHY
W. (1996) Frequency and morphologic characteristics of invasive
melanomas lacking specific surface microscopic features. Arch Dermatol
132: 1178-1182.
202. SHAW HM & McCARTHY WH. (1997) Small diameter
melanomas. Letter. J Cutan Pathol 24: 261-263.
203. McCARTHY WH & SHAW HM. (1996) Case finding
and interventions in high risk groups. Cancer Forum 20: 229-232.
204. MacKIE RM, CASCINELLI N, KIRKWOOD JM, ROSS MI,
SANTINAMI M & McCARTHY WH. (1996) Clinical management of melanoma.
WHO Melanoma Programme Publications, Number 4, Milan, pp 1-23.
205 HILL D, STALLEY P, PENNINGTON D, BESSER M, McCARTHY
WH. (1997) Competency-based learning in traumatology. Am J Surg
173: 136-140.
206. BUZAID AC, ROSS MI, BALCH CM, SOONG SJ, McCARTHY
WH, TINOCO L, MANSFIELD P, LEE JE, BEDIKIAN A, ETON O, PLAGER C,
PAPADOPOULOS N, LEGHA SS & BENJAMIN RS. (1997) Critical analysis
of the current American Joint Committee on Cancer Staging System
for cutaneous melanoma and proposal of a new staging system. J Clin
Oncol 15: 1039-1051.
207. HUANG X, SOONG SJ, McCARTHY WH, URIST MM &
BALCH CM. (1997) Classification of localized melanoma by the exponential
survival trees method. Cancer 79: 1122-1128.
208. MILTON GW, SHAW HM, THOMPSON JF & McCARTHY
WH. (1997) Cutaneous melanoma in childhood: incidence and prognosis.
Australas J Dermatol 38 (Suppl.): S44-S 48.
209. MENZIES SW, & McCARTHY WH. (1997) Complete
regression of primary cutaneous malignant melanoma. Arch Surg 132:
553-556
210. MENZIES SW, BISCHOF LM, PEDEN G, TALBOT HG, GUTENEV A, THOMPSON
RL, McNAMARA KW, BURLUTSKI G, McCARTHY WH & SKLADNEV VN. Automated
instrumentation for the diagnosis of invasive melanoma: image analysis
of oil epiluminescence microscopy. In: "Skin Cancer and UV
Radiation". P Altmeyer, K Hoffman & M Stucker (eds). Springer-Verlad
Berlin Heidelberg, pp 1065-1071, 1997.
211. O'BRIEN CJ, PETERSEN-SCHAEFER K, STEVENS G, BASS
P, TEW P, GEBSKI V, THOMPSON J & McCARTHY W. (1997) Adjuvant
radiotherapy following neck dissection and parotidectomy for metastatic
malignant melanoma. Head Neck 19: 589-594.
212. BATAILLE V, GRULICH A, SASIENI P, SWERDLOW A,
NEWTON BISHOP J, MCCARTHY W, HERSEY P & CUZICK J. (1998) The
association between naevi and melanoma in populations with different
levels of sun exposure: a joint case-control study of melanoma in
the UK and Australia. Br J Cancer 77: 505-510.
213. SHAW HM, THOMPSON JF & McCARTHY WH. (1998)
Ultra-Late recurrence (15 years or longer) of cutaneous melanoma.
Letter. Cancer 82: 1799-1800.
214. UREN RF, HOWMAN-GILES R, THOMPSON JF & McCARTHY
WH. (1998) Exclusive lymphatic drainage from a melanoma on the back
to intra-abdominal lymph nodes. Clin Nucl Med 23: 71-31.
215. McCARTHY WH & SHAW HM. (1998) The surgical
treatment of primary melanoma. Hematol Oncol Clin North Am 12: 797-805.
216. UREN R, HOWMAN-GILES R, THOMPSON JF, SHAW HM,
ROBERTS JM, BERNARD E & McCARTHY WH. (1999) High-resolution
ultrasound to diagnose melanoma metastases in patients with clinically
palpable lymph nodes. Australas Radiol:43: 148-152.
217. McCARTHY WH. Malignant Melanoma. In: "Cancer.
A Comprehensive Clinical Guide." D Morris, J Kearsley &
C Williams (eds). Harwood Academic Publishers, Amsterdam, pp 95-109,
1998.
218. QUINN MJ, CROTTY KA, THOMPSON JF, COATES AS,
O'BRIEN CJ & McCARTHY WH. (1998) Desmoplastic and desmoplastic
neurotropic melanoma: experience with 280 patients. Cancer 83: 1128-1135.
219. BATAILLE V, SASIENI P, GRULICH A, SWERDLOW A,
McCARTHY WH, HERSEY P, NEWTON BISHOP JA & CUZICK J. (1998) Solar
keratoses: a risk factor for melanoma but negative association with
melanocytic naevi. Int. J. Cancer 78: 8-12.
220. TALLEY L,I, SOONG SJ, HARRISON RA, McCARTHY WH,
URIST MM & BALCH CM. (1998) Clinical outcomes of localized melanoma
of the foot: a case-control study. J Clin Epidemiol 51: 853-857.
221. SOONG S-J, HARRISON RA, McCARTHY WH, URIST MM
& BALCH CM. (1998) Factors affecting survival following local,
regional, or distant recurrence from localized melanoma. J Surg
Oncol 67:, 228-233.
222. McCARTHY WH. (1998) Response to the article"Local
recurrence of melanoma." Letter. Australas J Dermatol 39: 132-133.
223. THOMPSON JF, UREN RF, SHAW HM, McCARTHY WH, QUINN
MJ, O'BRIEN CJ & HOWMAN-GILES R. (1999) Location of sentinel
lymph nodes in patients with cutaneous melanoma: new insights into
lymphatic anatomy. J Am Coll Surgeons 189: 195-206.
224. LARSSON KBM, SHAW HM, THOMPSON JF, HARMAN RC
& MCCARTHY WH. (1999) Primary mucosal and glans penis melanomas:
the Sydney Melanoma Unit experience. Aust NZJ Surg 69: 121-126.
225. McCARTHY WH. Melanoma and other skin cancers.
In: "Cancer Facts. A Concise Oncology Text." J Bishop
(ed). Harwood Academic Publishers, Amsterdam, pp 260-265, 1999.
226. McCARTHY WH. Public education programs in Australia:
a brief report. Skin Ca Found J.(In press)
227. McCARTHY WH. (2000) Evidence based guidance for
managing melanoma. Med J Aust 173: 286-287.
228. McCARTHY WH. (2000) Management of melanoma. Current
Therapeutics 41: 12-23.
229. McCARTHY WH. (2000) Melanoma. Complicated Cases.
Current therapeutics 41: 35-37.
230. STEVENS G, THOMPSON FJ, FIRTH I, O'BRIEN CJ,
McCARTHY WH & QUINN MJ. (2000) Locally advanced melanoma. Results
of postoperative hypofractionated radiation therapy. Cancer 88:
88-94.
231. UREN RF, HOWMAN-GILES R, THOMPSON JF, McCARTHY
WH, QUINN MJ, ROBERTS JM & SHAW HM. (2000) Interval nodes: the
forgotten sentinel nodes in melanoma patients. Arch Surg 135: 1168-1172.
232. MENZIES SW, WESTERHOFF K, RABINOWITZ H, KOPF
AW, McCARTHY WH & KATZ B. (2000) Surface microscopy of pigmented
basal cell carcinoma. Arch Dermatol 136: 1012-1016.
233. WESTERHOFF K, McCARTHY WH & MENZIES SW. (2000)
Increase in the sensitivity for melanoma diagnosis by primary care
physicians using skin surface microscopy. Br J Dermatol 143: 1016-1020.
234. McCARTHY WH. (2001) Melanoma, skin cancer &
sunlight. Check 356: 1-20.
235. MENZIES SW, GUTENEV A, AVRAMIDIS M, BATRAC A
& McCARTHY WH. (2001) Short-term digital surface microscopy
monitoring of atypical or changing melanocytic lesions. Arch Dermatol
137: 1583-1589.
236. ZACEST AC, BESSER M, STEVENS G, THOMPSON JF,
McCARTHY WH & CULJAK G. (2002) Surgical management of cerebral
metastases from melanoma: outcome in 147 patients treated at a single
institution over two decades. J Neurosurg 96: 552-558.
237. McCARTHY WH. (2002) Melanoma: margins for error
- another view. ANZ J Surg
72: 304-306.
238. SHAW HM, McCARTHY WH & SCOLYER RA. (2002)
Clinical and histologic features of level 2 cutaneous malignant
melanoma associated with metastasis. Cancer 95: 671-672. |
